Who we are

Dr. Jahan Marcu

Jahan Marcu, PhD, Editor in Chief

Dr. Jahan Marcu, Editor-In-Chief of AJEM, has over 15 years of experience in cannabinoid research, policy, and operations and has been a passionate advocate focused on consumer safety and the medical benefits of cannabis. He is also among a select group of professionals globally that has earned a PhD focused on the endocannabinoid system (with research on the structure and function of cannabinoid receptors, molecular pharmacology of the endocannabinoid system, and the role of the ECS in bone). His dedication to consumer safety is evident in his work to co-develop a biotech application to predict drug-drug interactions between cannabis and commonly prescribed pharmaceutical drugs. Additionally, Dr. Marcu published one of the first product safety study on CBD products.

He is the co-founder and former Chief Science Officer for the International Research Center on Cannabis and Health (aka Institute of Cannabis Research). He is also founder and past-chair of the Cannabis Chemistry Sub-division of the American Chemical Society, the world’s largest and oldest professional scientific society. Dr. Marcu is a recipient of the Mahmoud Elsohly award for excellence in cannabis chemistry and the Billy Martin research achievement award from the International Cannabinoid Research Society for his work on THC and CBD synergy in aggressive brain cancers. Dr. Marcu’s work has been published and covered in publications such as Science, Nature, JAMA, the Washington Post, and CNN. Some of his media appearances can also be viewed here and here.


Dr. Uma

Uma Dhanabalan, MD, MPH, FAAFP, Medical Director

Dr. Uma Dhanabalan, Medical Director of AJEM, is a highly respected physician trained in Family Medicine, Occupational & Environmental Medicine, specialized in heavy metals, a Fellow of the American Academy of Family Physicians, a Cannabinoid Medicine Specialist and Medical Review Officer. She completed a Family Practice Residency at the Medical University of South Carolina, in Charleston, South Carolina and her Master’s in Public Health and Occupational & Environmental Medicine Residency and Fellowship at the Harvard School of Public Health in Boston Massachusetts. She is also Certified by the American Academy of Cannabinoid Medicine and by the Medical Review Officer Certification Council. She has received awards from the 7th World Ayurveda Conference & Arogya Expo for her presentation “Cannabis & The Therapeutic Uses” and the Educational Achievement Award presented by Clover Leaf at Cannabis Business Award 2017.

Dr. Dhanabalan created the TotalHealthCareTHC model where she “Educates Embraces Empowers” patients and promotes cannabis as a treatment option at Uplifting Health and Wellness, in Natick, Massachusetts. She is an advocate, activist and educator and speaks globally about cannabis as a plant medicine. Her mission is to change the Stigma regarding Cannabis and for the world to know about the Endocannabinoid system through education. Here is Dr. Dhanabalan speaking at Fran Drescher’s Health Summit in 2017, appearing on Drescher’s CancerSchmancer “Corona Care 4 You” series and a video that provides additional information on her career as well as video of her testimony before the United States Senate in 2017.


Meg Block Roloff, MPH

Meg Bock Roloff is a medical journalist based in the New York City area. She specializes in writing and editing articles about medicine and the social issues that affect health outcomes. Currently, Meg is Managing Editor of the American Journal of Endocannabinoid Medicine (AJEM).

Meg has a strong research background and began her career 20 years ago working on sociomedical research studies in maternal and pediatric HIV at the HIV Center for Clinical and Behavioral Studies at the NYS Psychiatric Institute and Columbia University.

With her sights set on being a health journalist, Meg took magazine writing courses from Columbia’s prestigious Journalism School and obtained her Master’s in Public Health from Columbia University’s Mailman School of Public Health in Sociomedical Sciences with a certificate in Health Promotion and Disease Prevention. She obtained her undergraduate degree in psychology from the University of Rochester.

Meg started out as editor of a monthly medical trade publication where she covered major medical meetings and created content relevant to physicians across a variety of different medical specialties. She went on to serve as Managing Editor of Custom Publications and Custom Media, where she edited single-sponsored medical publications and hosted medical podcasts. Next, Meg transitioned to being a freelance medical journalist, writing and editing health articles for daily local newspapers, the hospital publications of NewYork-Presbyterian/Columbia and Weill Cornell Medicine, and various medical trade publications.

As Managing Editor of AJEM, Meg brings her strong medical and research background to the medical cannabis space. She sees immense potential for cannabinoid-based medications to promote health and prevent disease.

Meg lives in Westchester, NY, with her husband, two children, and new puppy.


Ken Watkins, Publisher

Ken Watkins, Publisher of AJEM, has a long, well established history in medical publishing. After two years of detailing cardiologists on antiarrhythmic drugs for Berlex Laboratories, Ken started his publishing career at Cliggott Publishing working on the primary care journal, Consultant. Ken went on to represent a number of different specialty and primary care journals before starting his first business, Watkins Representation Group (WRG). Their first publication was the internationally respected British Medical Journal. WRG went on to work with Medimedia, the American College of Physicians and many, smaller medical content firms. Ken then started Soken Communications in order to give life to custom publishing ideas he envisioned for individual products and stand-alone disease states. Soken Communications has gone on to produce print, digital and video programs for many different pharmaceutical companies.


Scott Rudder, Chief Strategy Officer

Scott Rudder, Chief Strategy Officer of AJEM, is a former New Jersey State Legislator and mayor with Fortune 100 corporate experience. Prior to joining AJEM, Scott founded the New Jersey CannaBusiness Association, New Jersey’s first and largest cannabis industry group, serving as its president for four years. Under Scott’s leadership, NJCBA led cannabis reform efforts to increase patient access to cannabis as a medicine as well as promotions to end outdated stigmas and stereotypes associated with cannabis prohibition. In addition, Scott helped lead efforts to pass New Jersey’s cannabis reform efforts via referendum in 2020.  His leadership helped put an end to cannabis prohibition and create a path for expungement for those who were previously arrested for simple cannabis possession.

In addition to his 16 years in elected office, which included serving as a member of New Jersey’s General Assembly, Scott worked in senior staff positions in multiple government organizations including a Member of Congress, Governor of New Jersey, Speaker of the General Assembly and served as the Director of Legislative Affairs for New Jersey Transit. Rudder also spent 13 years as a Business Development executive with Lockheed Martin, the nation’s largest defense contractor.  At Lockheed Martin, Scott led domestic and international business development campaigns that included missile defense, Special Forces technologies, as well as energy programs.